Back to today’s briefing

Story perspectives

U.S. Medicare to Negotiate Prices for 15 Drugs

1/21/2025

32 7

Summary

Story summary

In a groundbreaking move, the U.S. government has announced that 15 drugs, including the popular weight-loss medication Wegovy, will enter Medicare price negotiations in 2027. This initiative promises to improve access to vital GLP-1 medications for seniors, yet analysts caution that the impact on overall sales may be limited and uninsured patients could still face high costs. The goal? A significant 30% discount on current prices.

History

Historical Context

The U.S. government's decision to negotiate Medicare prices for 15 drugs, including Wegovy, reflects a growing trend of healthcare reform aimed at reducing prescription costs. This echoes past initiatives, such as the 2003 Medicare Modernization Act, which expanded drug coverage but faced criticism for high prices. The current negotiations aim for a 30% discount, addressing ongoing concerns about drug affordability for seniors.

1 of 2

Story summary

In a groundbreaking move, the U.S. government has announced that 15 drugs, including the popular weight-loss medication Wegovy, will enter Medicare price negotiations in 2027. This initiative promises to improve access to vital GLP-1 medications for seniors, yet analysts caution that the impact on overall sales may be limited and uninsured patients could still face high costs. The goal? A significant 30% discount on current prices.

1 / 2